Vinorelbine Actavis 50
Drug Category |
|
Medicinal form |
Vials |
Active ingredient |
|
Concentration |
50mg |
Manufacturer |
|
Price |
504 EGP |
Uses
Interactions : As for Vinblastine sulfate
Side effects: As for Vinblastine. The main dose-limiting effect of vinorelbine is granulocytopenia. The nadir of the granulocyte count occurs 5 to 10 days after a dose, with recovery after a further 7 to 14 days. & stopped if moderate or severe neurotoxicity develops. Local pain and thrombophlebitis may be seen with repeated injection of vinorelbine
Uses: advanced breast cancer and non-small cell lung cancers,& lymphomas and tumours of ovary and prostate Dosage: I.V. injection over 5 to 10 minutes, as a solution containing 1.5 to 3 mg/mL in glucose 5% or sodium chloride 0.9% injection, directly or into a freely-running intravenous infusion.
Note: The information provided about this drug does not substitute for consulting a doctor.
Direct Access to Pharmacy Through Innovative Portal
Empower your health journey with Direct Access to Pharmacy Through Innovative Portal - Your gateway to seamless and efficient healthcare solutions at your fingertips
See list pharmacies